Measurement of vitamin D and cathelicidin (LL-37) levels in patients of psoriasis with co-morbidities
Authors:
- Bayoumi EL EassaBEBayoumi EL Eassa
- Vasanthy NairVNVasanthy Nair
Open Access
- 1 January 2013
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 79 (4) , 492-496
Abstract
Background: During the last decade, a lot of co-morbidities (diabetes, obesity, heart disease, etc.) have been described to be associated with psoriasis, but the exact link at the molecular level is not well-known. Researchers have shown molecular level changes in vitamin D pathway and its relationship to cathelicidin. Aims: To estimate the levels of cathelicidin (LL-37), and vitamin D in psoriasis patients with co-morbidities, and compare them with matched healthy controls. Methods: One hundred consecutive patients with stable plaque psoriasis (psoriasis area and severity index ≥10) with no systemic treatment in the past 3 months were investigated for the serum levels of vitamin D and LL-37, and compared with equal number of matched healthy volunteers. Results: The serum vitamin D levels were significantly lower in patients. Furthermore, the levels of serum LL-37were significantly high. Conclusion: Our study showed that the low serum levels of vitamin D, and higher blood levels of cathelicidin could form a molecular level clue in the pathogenesis of psoriasis patients, who are more likely to develop co-morbidities.Keywords
This publication has 24 references indexed in Scilit:
- Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control studyJournal of the American Academy of Dermatology, 2012
- Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health StudiesBritish Journal of Nutrition, 2012
- Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic AcidJournal of Investigative Dermatology, 2010
- Control of cutaneous antimicrobial peptides by vitamin D3Archives of Dermatological Research, 2010
- Complexity of the Association Between Psoriasis and ComorbiditiesJournal of Investigative Dermatology, 2009
- Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D3Journal of Investigative Dermatology, 2008
- Vitamin D Regulation of Cathelicidin in the Skin: Toward a Renaissance of Vitamin D in Dermatology?Journal of Investigative Dermatology, 2008
- Psoriasis comorbiditiesJournal of Dermatological Treatment, 2008
- Evolution of the Primate CathelicidinJournal of Biological Chemistry, 2006
- Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D 3The FASEB Journal, 2005